English
简体中文
Total: £ 56.28
Published Date: 2026-04-13 | Pages: 118 | Tables: 113 | Pharma & Healthcare
The global Omalizumab Biologic Injection market was valued at US$ 64.92 million in 2025 and is anticipated to reach US$ 127 million by 2032, at a CAGR of 8.7% from 2026 to 2032.
Omalizumab Biologic Injection is a monoclonal antibody drug targeting immunoglobulin E (IgE), mainly used for the treatment of allergic asthma, chronic spontaneous urticaria, nasal polyps, and other IgE-mediated diseases. It works by binding to free IgE in the blood, thereby reducing allergic reactions and inflammation. Upstream of the industry chain mainly includes biotechnology raw materials, cell culture media, recombinant protein expression systems, bioreactor equipment, and contract development and manufacturing organizations (CDMOs). Midstream consists of biopharmaceutical companies producing original biologics and biosimilars, formulation manufacturers, fill-finish providers, and cold chain logistics companies. Downstream includes hospitals, specialty clinics, retail pharmacies, online pharmacies, and patients suffering from severe allergic or autoimmune-related conditions. With the growing prevalence of allergic diseases and the expansion of biologic therapies, the market demand for Omalizumab Injection continues to increase globally.
The North American market for Omalizumab Biologic Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Omalizumab Biologic Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Omalizumab Biologic Injection in Hospital is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Omalizumab Biologic Injection include Roche, Novartis, Glenmark Pharmaceuticals, Selexis, Generium, CuraTeQ, Celltrion Healthcare, Alvotech, BiosanaPharma, Mabpharm, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Omalizumab Biologic Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Omalizumab Biologic Injection. The Omalizumab Biologic Injection market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Omalizumab Biologic Injection market comprehensively. Regional market sizes by Type, by Application, by Age, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Omalizumab Biologic Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Roche
Novartis
Glenmark Pharmaceuticals
Selexis
Generium
CuraTeQ
Celltrion Healthcare
Alvotech
BiosanaPharma
Mabpharm
CSPC Pharmaceutical Group
Biomabs
HisunPharm
Segment by Type
150 mg/mL
75 mg/0.5 mL
Segment by Age
For Adults
For Teenagers
For Children
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Age, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Omalizumab Biologic Injection companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Omalizumab Biologic Injection Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 150 mg/mL
1.2.3 75 mg/0.5 mL
1.3 Market by Age
1.3.1 Global Omalizumab Biologic Injection Market Size Growth Rate by Age: 2021 vs 2025 vs 2032
1.3.2 For Adults
1.3.3 For Teenagers
1.3.4 For Children
1.4 Market by Application
1.4.1 Global Omalizumab Biologic Injection Market Growth by Application: 2021 vs 2025 vs 2032
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Omalizumab Biologic Injection Market Perspective (2021–2032)
2.2 Global Omalizumab Biologic Injection Growth Trends by Region
2.2.1 Global Omalizumab Biologic Injection Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Omalizumab Biologic Injection Historic Market Size by Region (2021–2026)
2.2.3 Omalizumab Biologic Injection Forecasted Market Size by Region (2027–2032)
2.3 Omalizumab Biologic Injection Market Dynamics
2.3.1 Omalizumab Biologic Injection Industry Trends
2.3.2 Omalizumab Biologic Injection Market Drivers
2.3.3 Omalizumab Biologic Injection Market Challenges
2.3.4 Omalizumab Biologic Injection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Omalizumab Biologic Injection Players by Revenue
3.1.1 Global Top Omalizumab Biologic Injection Players by Revenue (2021–2026)
3.1.2 Global Omalizumab Biologic Injection Revenue Market Share by Players (2021–2026)
3.2 Global Top Omalizumab Biologic Injection Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Omalizumab Biologic Injection Revenue
3.4 Global Omalizumab Biologic Injection Market Concentration Ratio
3.4.1 Global Omalizumab Biologic Injection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Omalizumab Biologic Injection Revenue in 2025
3.5 Global Key Players of Omalizumab Biologic Injection Head Offices and Areas Served
3.6 Global Key Players of Omalizumab Biologic Injection, Products and Applications
3.7 Global Key Players of Omalizumab Biologic Injection, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Omalizumab Biologic Injection Breakdown Data by Type
4.1 Global Omalizumab Biologic Injection Historic Market Size by Type (2021–2026)
4.2 Global Omalizumab Biologic Injection Forecasted Market Size by Type (2027–2032)
5 Omalizumab Biologic Injection Breakdown Data by Application
5.1 Global Omalizumab Biologic Injection Historic Market Size by Application (2021–2026)
5.2 Global Omalizumab Biologic Injection Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Omalizumab Biologic Injection Market Size (2021–2032)
6.2 North America Omalizumab Biologic Injection Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Omalizumab Biologic Injection Market Size by Country (2021–2026)
6.4 North America Omalizumab Biologic Injection Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Omalizumab Biologic Injection Market Size (2021–2032)
7.2 Europe Omalizumab Biologic Injection Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Omalizumab Biologic Injection Market Size by Country (2021–2026)
7.4 Europe Omalizumab Biologic Injection Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Omalizumab Biologic Injection Market Size (2021–2032)
8.2 Asia-Pacific Omalizumab Biologic Injection Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Omalizumab Biologic Injection Market Size by Region (2021–2026)
8.4 Asia-Pacific Omalizumab Biologic Injection Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Omalizumab Biologic Injection Market Size (2021–2032)
9.2 Latin America Omalizumab Biologic Injection Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Omalizumab Biologic Injection Market Size by Country (2021–2026)
9.4 Latin America Omalizumab Biologic Injection Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Omalizumab Biologic Injection Market Size (2021–2032)
10.2 Middle East & Africa Omalizumab Biologic Injection Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Omalizumab Biologic Injection Market Size by Country (2021–2026)
10.4 Middle East & Africa Omalizumab Biologic Injection Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Omalizumab Biologic Injection Introduction
11.1.4 Roche Revenue in Omalizumab Biologic Injection Business (2021–2026)
11.1.5 Roche Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Omalizumab Biologic Injection Introduction
11.2.4 Novartis Revenue in Omalizumab Biologic Injection Business (2021–2026)
11.2.5 Novartis Recent Development
11.3 Glenmark Pharmaceuticals
11.3.1 Glenmark Pharmaceuticals Company Details
11.3.2 Glenmark Pharmaceuticals Business Overview
11.3.3 Glenmark Pharmaceuticals Omalizumab Biologic Injection Introduction
11.3.4 Glenmark Pharmaceuticals Revenue in Omalizumab Biologic Injection Business (2021–2026)
11.3.5 Glenmark Pharmaceuticals Recent Development
11.4 Selexis
11.4.1 Selexis Company Details
11.4.2 Selexis Business Overview
11.4.3 Selexis Omalizumab Biologic Injection Introduction
11.4.4 Selexis Revenue in Omalizumab Biologic Injection Business (2021–2026)
11.4.5 Selexis Recent Development
11.5 Generium
11.5.1 Generium Company Details
11.5.2 Generium Business Overview
11.5.3 Generium Omalizumab Biologic Injection Introduction
11.5.4 Generium Revenue in Omalizumab Biologic Injection Business (2021–2026)
11.5.5 Generium Recent Development
11.6 CuraTeQ
11.6.1 CuraTeQ Company Details
11.6.2 CuraTeQ Business Overview
11.6.3 CuraTeQ Omalizumab Biologic Injection Introduction
11.6.4 CuraTeQ Revenue in Omalizumab Biologic Injection Business (2021–2026)
11.6.5 CuraTeQ Recent Development
11.7 Celltrion Healthcare
11.7.1 Celltrion Healthcare Company Details
11.7.2 Celltrion Healthcare Business Overview
11.7.3 Celltrion Healthcare Omalizumab Biologic Injection Introduction
11.7.4 Celltrion Healthcare Revenue in Omalizumab Biologic Injection Business (2021–2026)
11.7.5 Celltrion Healthcare Recent Development
11.8 Alvotech
11.8.1 Alvotech Company Details
11.8.2 Alvotech Business Overview
11.8.3 Alvotech Omalizumab Biologic Injection Introduction
11.8.4 Alvotech Revenue in Omalizumab Biologic Injection Business (2021–2026)
11.8.5 Alvotech Recent Development
11.9 BiosanaPharma
11.9.1 BiosanaPharma Company Details
11.9.2 BiosanaPharma Business Overview
11.9.3 BiosanaPharma Omalizumab Biologic Injection Introduction
11.9.4 BiosanaPharma Revenue in Omalizumab Biologic Injection Business (2021–2026)
11.9.5 BiosanaPharma Recent Development
11.10 Mabpharm
11.10.1 Mabpharm Company Details
11.10.2 Mabpharm Business Overview
11.10.3 Mabpharm Omalizumab Biologic Injection Introduction
11.10.4 Mabpharm Revenue in Omalizumab Biologic Injection Business (2021–2026)
11.10.5 Mabpharm Recent Development
11.11 CSPC Pharmaceutical Group
11.11.1 CSPC Pharmaceutical Group Company Details
11.11.2 CSPC Pharmaceutical Group Business Overview
11.11.3 CSPC Pharmaceutical Group Omalizumab Biologic Injection Introduction
11.11.4 CSPC Pharmaceutical Group Revenue in Omalizumab Biologic Injection Business (2021–2026)
11.11.5 CSPC Pharmaceutical Group Recent Development
11.12 Biomabs
11.12.1 Biomabs Company Details
11.12.2 Biomabs Business Overview
11.12.3 Biomabs Omalizumab Biologic Injection Introduction
11.12.4 Biomabs Revenue in Omalizumab Biologic Injection Business (2021–2026)
11.12.5 Biomabs Recent Development
11.13 HisunPharm
11.13.1 HisunPharm Company Details
11.13.2 HisunPharm Business Overview
11.13.3 HisunPharm Omalizumab Biologic Injection Introduction
11.13.4 HisunPharm Revenue in Omalizumab Biologic Injection Business (2021–2026)
11.13.5 HisunPharm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Omalizumab Biologic Injection Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of 150 mg/mL
Table 3. Key Players of 75 mg/0.5 mL
Table 4. Global Omalizumab Biologic Injection Market Size Growth Rate by Age (US$ Million): 2021 vs 2025 vs 2032
Table 5. Key Players of For Adults
Table 6. Key Players of For Teenagers
Table 7. Key Players of For Children
Table 8. Global Omalizumab Biologic Injection Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 9. Global Omalizumab Biologic Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 10. Global Omalizumab Biologic Injection Market Size by Region (US$ Million), 2021–2026
Table 11. Global Omalizumab Biologic Injection Market Share by Region (2021–2026)
Table 12. Global Omalizumab Biologic Injection Forecasted Market Size by Region (US$ Million), 2027–2032
Table 13. Global Omalizumab Biologic Injection Market Share by Region (2027–2032)
Table 14. Omalizumab Biologic Injection Market Trends
Table 15. Omalizumab Biologic Injection Market Drivers
Table 16. Omalizumab Biologic Injection Market Challenges
Table 17. Omalizumab Biologic Injection Market Restraints
Table 18. Global Omalizumab Biologic Injection Revenue by Players (US$ Million), 2021–2026
Table 19. Global Omalizumab Biologic Injection Market Share by Players (2021–2026)
Table 20. Global Top Omalizumab Biologic Injection Players by Tier (Tier 1, Tier 2, and Tier 3), based on Omalizumab Biologic Injection Revenue, 2025
Table 21. Ranking of Global Top Omalizumab Biologic Injection Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Omalizumab Biologic Injection Revenue (CR5 and HHI), 2021–2026
Table 23. Global Key Players of Omalizumab Biologic Injection, Headquarters and Area Served
Table 24. Global Key Players of Omalizumab Biologic Injection, Products and Applications
Table 25. Global Key Players of Omalizumab Biologic Injection, Date of General Availability (GA)
Table 26. Mergers and Acquisitions, Expansion Plans
Table 27. Global Omalizumab Biologic Injection Market Size by Type (US$ Million), 2021–2026
Table 28. Global Omalizumab Biologic Injection Revenue Market Share by Type (2021–2026)
Table 29. Global Omalizumab Biologic Injection Forecasted Market Size by Type (US$ Million), 2027–2032
Table 30. Global Omalizumab Biologic Injection Revenue Market Share by Type (2027–2032)
Table 31. Global Omalizumab Biologic Injection Market Size by Application (US$ Million), 2021–2026
Table 32. Global Omalizumab Biologic Injection Revenue Market Share by Application (2021–2026)
Table 33. Global Omalizumab Biologic Injection Forecasted Market Size by Application (US$ Million), 2027–2032
Table 34. Global Omalizumab Biologic Injection Revenue Market Share by Application (2027–2032)
Table 35. North America Omalizumab Biologic Injection Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. North America Omalizumab Biologic Injection Market Size by Country (US$ Million), 2021–2026
Table 37. North America Omalizumab Biologic Injection Market Size by Country (US$ Million), 2027–2032
Table 38. Europe Omalizumab Biologic Injection Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 39. Europe Omalizumab Biologic Injection Market Size by Country (US$ Million), 2021–2026
Table 40. Europe Omalizumab Biologic Injection Market Size by Country (US$ Million), 2027–2032
Table 41. Asia-Pacific Omalizumab Biologic Injection Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 42. Asia-Pacific Omalizumab Biologic Injection Market Size by Region (US$ Million), 2021–2026
Table 43. Asia-Pacific Omalizumab Biologic Injection Market Size by Region (US$ Million), 2027–2032
Table 44. Latin America Omalizumab Biologic Injection Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Latin America Omalizumab Biologic Injection Market Size by Country (US$ Million), 2021–2026
Table 46. Latin America Omalizumab Biologic Injection Market Size by Country (US$ Million), 2027–2032
Table 47. Middle East & Africa Omalizumab Biologic Injection Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 48. Middle East & Africa Omalizumab Biologic Injection Market Size by Country (US$ Million), 2021–2026
Table 49. Middle East & Africa Omalizumab Biologic Injection Market Size by Country (US$ Million), 2027–2032
Table 50. Roche Company Details
Table 51. Roche Business Overview
Table 52. Roche Omalizumab Biologic Injection Product
Table 53. Roche Revenue in Omalizumab Biologic Injection Business (US$ Million), 2021–2026
Table 54. Roche Recent Development
Table 55. Novartis Company Details
Table 56. Novartis Business Overview
Table 57. Novartis Omalizumab Biologic Injection Product
Table 58. Novartis Revenue in Omalizumab Biologic Injection Business (US$ Million), 2021–2026
Table 59. Novartis Recent Development
Table 60. Glenmark Pharmaceuticals Company Details
Table 61. Glenmark Pharmaceuticals Business Overview
Table 62. Glenmark Pharmaceuticals Omalizumab Biologic Injection Product
Table 63. Glenmark Pharmaceuticals Revenue in Omalizumab Biologic Injection Business (US$ Million), 2021–2026
Table 64. Glenmark Pharmaceuticals Recent Development
Table 65. Selexis Company Details
Table 66. Selexis Business Overview
Table 67. Selexis Omalizumab Biologic Injection Product
Table 68. Selexis Revenue in Omalizumab Biologic Injection Business (US$ Million), 2021–2026
Table 69. Selexis Recent Development
Table 70. Generium Company Details
Table 71. Generium Business Overview
Table 72. Generium Omalizumab Biologic Injection Product
Table 73. Generium Revenue in Omalizumab Biologic Injection Business (US$ Million), 2021–2026
Table 74. Generium Recent Development
Table 75. CuraTeQ Company Details
Table 76. CuraTeQ Business Overview
Table 77. CuraTeQ Omalizumab Biologic Injection Product
Table 78. CuraTeQ Revenue in Omalizumab Biologic Injection Business (US$ Million), 2021–2026
Table 79. CuraTeQ Recent Development
Table 80. Celltrion Healthcare Company Details
Table 81. Celltrion Healthcare Business Overview
Table 82. Celltrion Healthcare Omalizumab Biologic Injection Product
Table 83. Celltrion Healthcare Revenue in Omalizumab Biologic Injection Business (US$ Million), 2021–2026
Table 84. Celltrion Healthcare Recent Development
Table 85. Alvotech Company Details
Table 86. Alvotech Business Overview
Table 87. Alvotech Omalizumab Biologic Injection Product
Table 88. Alvotech Revenue in Omalizumab Biologic Injection Business (US$ Million), 2021–2026
Table 89. Alvotech Recent Development
Table 90. BiosanaPharma Company Details
Table 91. BiosanaPharma Business Overview
Table 92. BiosanaPharma Omalizumab Biologic Injection Product
Table 93. BiosanaPharma Revenue in Omalizumab Biologic Injection Business (US$ Million), 2021–2026
Table 94. BiosanaPharma Recent Development
Table 95. Mabpharm Company Details
Table 96. Mabpharm Business Overview
Table 97. Mabpharm Omalizumab Biologic Injection Product
Table 98. Mabpharm Revenue in Omalizumab Biologic Injection Business (US$ Million), 2021–2026
Table 99. Mabpharm Recent Development
Table 100. CSPC Pharmaceutical Group Company Details
Table 101. CSPC Pharmaceutical Group Business Overview
Table 102. CSPC Pharmaceutical Group Omalizumab Biologic Injection Product
Table 103. CSPC Pharmaceutical Group Revenue in Omalizumab Biologic Injection Business (US$ Million), 2021–2026
Table 104. CSPC Pharmaceutical Group Recent Development
Table 105. Biomabs Company Details
Table 106. Biomabs Business Overview
Table 107. Biomabs Omalizumab Biologic Injection Product
Table 108. Biomabs Revenue in Omalizumab Biologic Injection Business (US$ Million), 2021–2026
Table 109. Biomabs Recent Development
Table 110. HisunPharm Company Details
Table 111. HisunPharm Business Overview
Table 112. HisunPharm Omalizumab Biologic Injection Product
Table 113. HisunPharm Revenue in Omalizumab Biologic Injection Business (US$ Million), 2021–2026
Table 114. HisunPharm Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. Authors List of This Report
List of Figures
Figure 1. Omalizumab Biologic Injection Picture
Figure 2. Global Omalizumab Biologic Injection Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Omalizumab Biologic Injection Market Share by Type: 2025 vs 2032
Figure 4. 150 mg/mL Features
Figure 5. 75 mg/0.5 mL Features
Figure 6. Global Omalizumab Biologic Injection Market Size Comparison by Age (US$ Million), 2021–2032
Figure 7. For Adults Features
Figure 8. For Teenagers Features
Figure 9. For Children Features
Figure 10. Global Omalizumab Biologic Injection Market Size by Application (US$ Million), 2021–2032
Figure 11. Global Omalizumab Biologic Injection Market Share by Application: 2025 vs 2032
Figure 12. Hospital Case Studies
Figure 13. Clinic Case Studies
Figure 14. Others Case Studies
Figure 15. Omalizumab Biologic Injection Report Years Considered
Figure 16. Global Omalizumab Biologic Injection Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 17. Global Omalizumab Biologic Injection Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global Omalizumab Biologic Injection Market Share by Region: 2025 vs 2032
Figure 19. Global Omalizumab Biologic Injection Market Share by Players in 2025
Figure 20. Global Omalizumab Biologic Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. The Top 10 and 5 Players Market Share by Omalizumab Biologic Injection Revenue in 2025
Figure 22. North America Omalizumab Biologic Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. North America Omalizumab Biologic Injection Market Share by Country (2021–2032)
Figure 24. United States Omalizumab Biologic Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Canada Omalizumab Biologic Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Omalizumab Biologic Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Europe Omalizumab Biologic Injection Market Share by Country (2021–2032)
Figure 28. Germany Omalizumab Biologic Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. France Omalizumab Biologic Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. U.K. Omalizumab Biologic Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Italy Omalizumab Biologic Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Russia Omalizumab Biologic Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Ireland Omalizumab Biologic Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Omalizumab Biologic Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Asia-Pacific Omalizumab Biologic Injection Market Share by Region (2021–2032)
Figure 36. China Omalizumab Biologic Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Japan Omalizumab Biologic Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. South Korea Omalizumab Biologic Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Southeast Asia Omalizumab Biologic Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. India Omalizumab Biologic Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Australia & New Zealand Omalizumab Biologic Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Omalizumab Biologic Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Latin America Omalizumab Biologic Injection Market Share by Country (2021–2032)
Figure 44. Mexico Omalizumab Biologic Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Brazil Omalizumab Biologic Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Omalizumab Biologic Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Middle East & Africa Omalizumab Biologic Injection Market Share by Country (2021–2032)
Figure 48. Israel Omalizumab Biologic Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Saudi Arabia Omalizumab Biologic Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. UAE Omalizumab Biologic Injection Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Roche Revenue Growth Rate in Omalizumab Biologic Injection Business (2021–2026)
Figure 52. Novartis Revenue Growth Rate in Omalizumab Biologic Injection Business (2021–2026)
Figure 53. Glenmark Pharmaceuticals Revenue Growth Rate in Omalizumab Biologic Injection Business (2021–2026)
Figure 54. Selexis Revenue Growth Rate in Omalizumab Biologic Injection Business (2021–2026)
Figure 55. Generium Revenue Growth Rate in Omalizumab Biologic Injection Business (2021–2026)
Figure 56. CuraTeQ Revenue Growth Rate in Omalizumab Biologic Injection Business (2021–2026)
Figure 57. Celltrion Healthcare Revenue Growth Rate in Omalizumab Biologic Injection Business (2021–2026)
Figure 58. Alvotech Revenue Growth Rate in Omalizumab Biologic Injection Business (2021–2026)
Figure 59. BiosanaPharma Revenue Growth Rate in Omalizumab Biologic Injection Business (2021–2026)
Figure 60. Mabpharm Revenue Growth Rate in Omalizumab Biologic Injection Business (2021–2026)
Figure 61. CSPC Pharmaceutical Group Revenue Growth Rate in Omalizumab Biologic Injection Business (2021–2026)
Figure 62. Biomabs Revenue Growth Rate in Omalizumab Biologic Injection Business (2021–2026)
Figure 63. HisunPharm Revenue Growth Rate in Omalizumab Biologic Injection Business (2021–2026)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
